Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients
Abstract Background Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression includes cutaneous fibrofolliculomas, renal tumors, multiple pulmonary cysts, and recurrent spontaneous pneumothoraces. Data on...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01402-y |
id |
doaj-466fe3960a5340c4bf1a5660c39919e7 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
C. Daccord V. Cottin G. Prévot Y. Uzunhan J. F. Mornex P. Bonniaud R. Borie A. Briault M. A. Collonge-Rame B. Crestani G. Devouassoux O. Freynet A. Gondouin P. A. Hauss C. Khouatra S. Leroy S. Marchand-Adam C. Marquette D. Montani J. M. Naccache G. Nadeau N. Poulalhon M. Reynaud-Gaubert M. Salaun B. Wallaert J. F. Cordier M. Faouzi R. Lazor the OrphaLung network |
spellingShingle |
C. Daccord V. Cottin G. Prévot Y. Uzunhan J. F. Mornex P. Bonniaud R. Borie A. Briault M. A. Collonge-Rame B. Crestani G. Devouassoux O. Freynet A. Gondouin P. A. Hauss C. Khouatra S. Leroy S. Marchand-Adam C. Marquette D. Montani J. M. Naccache G. Nadeau N. Poulalhon M. Reynaud-Gaubert M. Salaun B. Wallaert J. F. Cordier M. Faouzi R. Lazor the OrphaLung network Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients Orphanet Journal of Rare Diseases Birt-Hogg-Dube syndrome FLCN protein, human Respiratory function tests Pleurodesis |
author_facet |
C. Daccord V. Cottin G. Prévot Y. Uzunhan J. F. Mornex P. Bonniaud R. Borie A. Briault M. A. Collonge-Rame B. Crestani G. Devouassoux O. Freynet A. Gondouin P. A. Hauss C. Khouatra S. Leroy S. Marchand-Adam C. Marquette D. Montani J. M. Naccache G. Nadeau N. Poulalhon M. Reynaud-Gaubert M. Salaun B. Wallaert J. F. Cordier M. Faouzi R. Lazor the OrphaLung network |
author_sort |
C. Daccord |
title |
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients |
title_short |
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients |
title_full |
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients |
title_fullStr |
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients |
title_full_unstemmed |
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients |
title_sort |
lung function in birt-hogg-dubé syndrome: a retrospective analysis of 96 patients |
publisher |
BMC |
series |
Orphanet Journal of Rare Diseases |
issn |
1750-1172 |
publishDate |
2020-05-01 |
description |
Abstract Background Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression includes cutaneous fibrofolliculomas, renal tumors, multiple pulmonary cysts, and recurrent spontaneous pneumothoraces. Data on lung function in BHD are scarce and it is not known whether lung function declines over time. We retrospectively assessed lung function at baseline and during follow-up in 96 patients with BHD. Results Ninety-five percent of BHD patients had multiple pulmonary cysts on computed tomography and 59% had experienced at least one pneumothorax. Mean values of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and total lung capacity were normal at baseline. Mean (standard deviation) residual volume (RV) was moderately increased to 116 (36) %pred at baseline, and RV was elevated > 120%pred in 41% of cases. Mean (standard deviation) carbon monoxide transfer factor (DLco) was moderately decreased to 85 (18) %pred at baseline, and DLco was decreased < 80%pred in 33% of cases. When adjusted for age, gender, smoking and history of pleurodesis, lung function parameters did not significantly decline over a follow-up period of 6 years. Conclusions Cystic lung disease in BHD does not affect respiratory function at baseline except for slightly increased RV and reduced DLco. No significant deterioration of lung function occurs in BHD over a follow-up period of 6 years. |
topic |
Birt-Hogg-Dube syndrome FLCN protein, human Respiratory function tests Pleurodesis |
url |
http://link.springer.com/article/10.1186/s13023-020-01402-y |
work_keys_str_mv |
AT cdaccord lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT vcottin lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT gprevot lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT yuzunhan lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT jfmornex lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT pbonniaud lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT rborie lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT abriault lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT macollongerame lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT bcrestani lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT gdevouassoux lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT ofreynet lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT agondouin lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT pahauss lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT ckhouatra lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT sleroy lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT smarchandadam lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT cmarquette lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT dmontani lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT jmnaccache lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT gnadeau lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT npoulalhon lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT mreynaudgaubert lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT msalaun lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT bwallaert lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT jfcordier lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT mfaouzi lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT rlazor lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients AT theorphalungnetwork lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients |
_version_ |
1724507747458744320 |
spelling |
doaj-466fe3960a5340c4bf1a5660c39919e72020-11-25T03:46:07ZengBMCOrphanet Journal of Rare Diseases1750-11722020-05-011511810.1186/s13023-020-01402-yLung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patientsC. Daccord0V. Cottin1G. Prévot2Y. Uzunhan3J. F. Mornex4P. Bonniaud5R. Borie6A. Briault7M. A. Collonge-Rame8B. Crestani9G. Devouassoux10O. Freynet11A. Gondouin12P. A. Hauss13C. Khouatra14S. Leroy15S. Marchand-Adam16C. Marquette17D. Montani18J. M. Naccache19G. Nadeau20N. Poulalhon21M. Reynaud-Gaubert22M. Salaun23B. Wallaert24J. F. Cordier25M. Faouzi26R. Lazor27the OrphaLung networkService de pneumologie, Centre hospitalier universitaire vaudois, Université de LausanneService de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1Service de pneumologie, Centre hospitalier universitaire de ToulouseService de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Avicenne, INSERM UMR 1272, Université Paris 13Service de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1Service de Pneumologie et Soins Intensifs Respiratoires, Centre hospitalier universitaire Dijon/Bourgogne, Université Bourgogne-Franche Comté, INSERM U123-1Service de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat - Claude BernardService de pneumologie, Centre hospitalier universitaire de GrenobleService de génétique biologique - histologie, UF cytogénétique, UF consultations d’oncogénétique, Centre hospitalier universitaire de BesançonService de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat - Claude BernardService de pneumologie, Hospices Civils de Lyon, Hôpital de la Croix-RousseService de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Avicenne, INSERM UMR 1272, Université Paris 13Service de pneumologie, Centre hospitalier universitaire de BesançonCentre hospitalier intercommunal Elbeuf - Louviers - Val de ReuilService de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1Service de pneumologie, Université Côte d’Azur, Centre hospitalier universitaire de Nice, CNRS, INSERM, FHU OncoAgeService de pneumologie, Centre hospitalier universitaire de ToursService de pneumologie, Université Côte d’Azur, Centre hospitalier universitaire de Nice, CNRS, INSERM, FHU OncoAgeService de Pneumologie, Université Paris–Sud, Assistance Publique Hôpitaux de Paris, INSERM UMR S999, Hôpital de BicêtreService de Pneumologie, Site constitutif du Centre de référence des maladies pulmonaires rares OrphaLung, Assistance Publique Hôpitaux de Paris, Hôpital TenonCentre hospitalier Métropole Savoie, UF de Génétique chromosomiqueService de dermatologie, Hospices Civils de Lyon, Centre hospitalier Lyon-SudService de pneumologie, Centre de compétences des maladies pulmonaires rares, Assistance Publique Hôpitaux de Marseille, Centre hospitalier universitaire de Marseille, Aix Marseille UniversitéService de pneumologie, Centre hospitalier universitaire de RouenService de pneumologie, Centre hospitalier universitaire de LilleService de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1Division de biostatistique, Centre universitaire de médecine générale et santé publique (Unisanté), Université de LausanneService de pneumologie, Centre hospitalier universitaire vaudois, Université de LausanneAbstract Background Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression includes cutaneous fibrofolliculomas, renal tumors, multiple pulmonary cysts, and recurrent spontaneous pneumothoraces. Data on lung function in BHD are scarce and it is not known whether lung function declines over time. We retrospectively assessed lung function at baseline and during follow-up in 96 patients with BHD. Results Ninety-five percent of BHD patients had multiple pulmonary cysts on computed tomography and 59% had experienced at least one pneumothorax. Mean values of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and total lung capacity were normal at baseline. Mean (standard deviation) residual volume (RV) was moderately increased to 116 (36) %pred at baseline, and RV was elevated > 120%pred in 41% of cases. Mean (standard deviation) carbon monoxide transfer factor (DLco) was moderately decreased to 85 (18) %pred at baseline, and DLco was decreased < 80%pred in 33% of cases. When adjusted for age, gender, smoking and history of pleurodesis, lung function parameters did not significantly decline over a follow-up period of 6 years. Conclusions Cystic lung disease in BHD does not affect respiratory function at baseline except for slightly increased RV and reduced DLco. No significant deterioration of lung function occurs in BHD over a follow-up period of 6 years.http://link.springer.com/article/10.1186/s13023-020-01402-yBirt-Hogg-Dube syndromeFLCN protein, humanRespiratory function testsPleurodesis |